Clinical Trial Update: Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting results from a Phase 1/2 study of OPB-31121 in progressive hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OPB-31121 (OPB-31121)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-06-08